Compare APTV & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APTV | ASND |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | Switzerland | Denmark |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5B | 15.2B |
| IPO Year | 2011 | 2014 |
| Metric | APTV | ASND |
|---|---|---|
| Price | $58.63 | $267.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 16 |
| Target Price | $88.80 | ★ $281.50 |
| AVG Volume (30 Days) | ★ 2.7M | 704.2K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.88 | N/A |
| Revenue | ★ $20,398,000,000.00 | N/A |
| Revenue This Year | $7.40 | $96.35 |
| Revenue Next Year | $4.87 | $44.91 |
| P/E Ratio | $66.01 | ★ N/A |
| Revenue Growth | ★ 3.47 | N/A |
| 52 Week Low | $51.68 | $161.09 |
| 52 Week High | $88.93 | $282.15 |
| Indicator | APTV | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 43.65 | 61.59 |
| Support Level | $56.94 | $213.28 |
| Resistance Level | $62.70 | N/A |
| Average True Range (ATR) | 2.19 | 9.94 |
| MACD | -0.21 | -0.15 |
| Stochastic Oscillator | 36.53 | 67.75 |
Aptiv PLC is an industrial technology company focused on enabling a more automated, electrified and digitalized future. The company's technologies reach from sensor to cloud, including the hardware and software necessary to support automotive and other industries on a global basis. Its Advanced Safety and User Experience segment provides advanced software and services, intelligent sensors and high-performance compute platforms; its Engineered Components Group segment provides connection systems, high-performance interconnects, and cable management and protection solutions; and its Electrical Distribution Systems segment provides low voltage and high voltage power, signal and data distribution.
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.